These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26094595)

  • 1. Hypoxia in astrocytic tumors and implications for therapy.
    Cavazos DA; Brenner AJ
    Neurobiol Dis; 2016 Jan; 85():227-233. PubMed ID: 26094595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant glioma physiology: cellular response to hypoxia and its role in tumor progression.
    Brat DJ; Mapstone TB
    Ann Intern Med; 2003 Apr; 138(8):659-68. PubMed ID: 12693889
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic and hypoxic regulation of angiogenesis in gliomas.
    Kaur B; Tan C; Brat DJ; Post DE; Van Meir EG
    J Neurooncol; 2004 Nov; 70(2):229-43. PubMed ID: 15674480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
    Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
    J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors.
    Sharma V; Purkait S; Takkar S; Malgulwar PB; Kumar A; Pathak P; Suri V; Sharma MC; Suri A; Kale SS; Kulshreshtha R; Sarkar C
    Brain Tumor Pathol; 2016 Apr; 33(2):117-28. PubMed ID: 26746204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation.
    Fountzilas G; Karkavelas G; Kalogera-Fountzila A; Karina M; Ignatiadis M; Koukoulis G; Plataniotis G; Misailidou D; Bobos M; Pectasides D; Razis E; Karavelis A; Selviaridis P
    Anticancer Res; 2006; 26(6C):4675-86. PubMed ID: 17214326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12-induced upregulation of FOXM1 expression promotes human glioblastoma cell invasion.
    Wang S; Zhang S; Li J; Xu X; Weng Y; Zheng M; Ouyang L; Li F
    Biochem Biophys Res Commun; 2014 Apr; 447(1):1-6. PubMed ID: 24561124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New frontiers for astrocytic tumours.
    Nano R; Lascialfari A; Corti M; Paolini A; Pasi F; Corbella F; DI Liberto R
    Anticancer Res; 2012 Jul; 32(7):2755-8. PubMed ID: 22753735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant astrocytic glioma: genetics, biology, and paths to treatment.
    Furnari FB; Fenton T; Bachoo RM; Mukasa A; Stommel JM; Stegh A; Hahn WC; Ligon KL; Louis DN; Brennan C; Chin L; DePinho RA; Cavenee WK
    Genes Dev; 2007 Nov; 21(21):2683-710. PubMed ID: 17974913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches.
    Huang WJ; Chen WW; Zhang X
    Oncol Lett; 2016 Oct; 12(4):2283-2288. PubMed ID: 27698790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor.
    Ishii N; Tada M; Hamou MF; Janzer RC; Meagher-Villemure K; Wiestler OD; Tribolet N; Van Meir EG
    Oncogene; 1999 Oct; 18(43):5870-8. PubMed ID: 10557074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of oxidative phosphorylation complexes in astrocytomas.
    Feichtinger RG; Weis S; Mayr JA; Zimmermann F; Geilberger R; Sperl W; Kofler B
    Glia; 2014 Apr; 62(4):514-25. PubMed ID: 24446254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of malignant supratentorial tumor of astrocytic origin].
    Poisson M; Delattre JY
    Rev Prat; 1990 Apr; 40(12):1114-6. PubMed ID: 2161130
    [No Abstract]   [Full Text] [Related]  

  • 14. p53 protein overexpression in astrocytic neoplasms.
    Cho MY; Jung SH; Kim TS
    Yonsei Med J; 1995 Dec; 36(6):521-6. PubMed ID: 8599254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High grade astrocytomas in children: Hartford Hospital experience.
    Hall AJ; Wagle VG; Voytek T
    Conn Med; 1991 Mar; 55(3):135-8. PubMed ID: 1647288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.
    Liu SY; Chiang MF; Chen YJ
    Exp Biol Med (Maywood); 2015 Mar; 240(3):315-23. PubMed ID: 25432984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
    Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
    Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.
    Marton E; Feletti A; Orvieto E; Longatti P
    J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
    Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
    PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.